The SIRT1 enzyme has been widely described as a challenging target for multiple strategies addressed for the prevention/treatment of several chronic age-related diseases, including myocardial infarct [16,19,37,38,39,45]. The gene discussed is SIRT1; the disease is myocardial infarction.